STOCKS | Eli Lilly Expects $2.8 Billion Pretax Charge in Second Quarter of 2026 From Acquired R&D Projects
2026-07-08 21:05:55
Eli Lilly said it expects a $2.8 billion pretax charge in the second quarter of 2026 related to research and development projects acquired through an acquisition. According to Jin10, the company said the charge would be equivalent to an impact of $3.02 per share.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
